HJ Science(06132.HK): Stabilisation Period Ends, Over-allotment Option Lapses
NewTimeSpace News: On 17 July 2026,HJ Science(06132.HK) issued an announcement stating that the stabilisation period relating to the global offering concluded on 17 July.
During the stabilisation period, the stabilising manager over-allocated a total of 2,040,000 H Shares under the international offering and subsequently repurchased a total of 2,040,000 H Shares in the market at prices ranging from HK$32.26 to HK$81.80 per share. As the over-allotment option remained unexercised, it lapsed on 17 July.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HJ Science Passes HKEX Listing Hearing, Core Products Cover Autoimmune, Metabolic and Oncology Fields
- HJ SCIENCE-B(06132.HK) closed 9.79% lower on Jul 17, the Hang Seng Pharmaceuticals & Biotechnology Sector posted broad declines
- HJ SCIENCE-B(06132.HK) closed 15.38% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- HJ SCIENCE-B(06132.HK) closed 38.03% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- HJ SCIENCE-B(06132.HK) Plunges 56.89% on Debut, Closing at HK$35.26
